抗磷脂综合征
语句(逻辑)
医学
十一
协商一致会议
梅德林
家庭医学
临床试验
血栓形成
内科学
重症监护医学
政治学
免疫学
抗体
法学
物理
声学
作者
Spiros Miyakis,Michael D. Lockshin,Tatsuya Atsumi,D. Ware Branch,Robin L. Brey,Ricard Cervera,R. H. W. M. Derksen,Philip G. de Groot,Takao Koike,Pier Luigi Meroni,Guido Reber,Yehuda Shoenfeld,Anǵela Tincani,Panayiotis G. Vlachoyiannopoulos,Steven A. Krilis
标识
DOI:10.1111/j.1538-7836.2006.01753.x
摘要
Summary. New clinical, laboratory and experimental insights, since the 1999 publication of the Sapporo preliminary classification criteria for antiphospholipid syndrome (APS), had been addressed at a workshop in Sydney, Australia, before the Eleventh International Congress on antiphospholipid antibodies. In this document, we appraise the existing evidence on clinical and laboratory features of APS addressed during the forum. Based on this, we propose amendments to the Sapporo criteria. We also provide definitions on features of APS that were not included in the updated criteria.
科研通智能强力驱动
Strongly Powered by AbleSci AI